comparison of bupropion and ritaline in the treatment of children with ADHD

comparison of bupropion and ritaline in the treatment of children with ADHD: a double blind trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201012021556N18

Enrollment

Registered

2010-12-04

Start date

2010-05-14

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disturbance of activity and attention. Disturbance of activity and attention

Interventions

Intervention 1: Tablet Bupropion(200 to 300 mg/day) as intervention group for 6 weeks. Intervention 2: Tablet Ritalin 20-30 mg/kg/day for 6 weeks as control group.

Treatment - Drugs

Tablet Bupropion(200 to 300 mg/day) as intervention group for 6 weeks

Tablet Ritalin 20-30 mg/kg/day for 6 weeks as control group

Eligibility

Sex/Gender

All

Age

6 Years to 17 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Diagnosis of ADHD based on DSM-IV, age between 6-17 Exclusion Criteria: receiving of any psychotropics drugs during past two weeks, presence of any psychiatric disorders or mental retardation (I.Q. 125, resting pulse rate 115/minute, zinc deficiency, lead intoxication

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Severity of ADHD. Timepoint: Week 0 (before treatment) and Weeks 3 and 6 after treatment. Method of measurement: Teacher and Parent ADHD Rating Scale.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026